Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Chlortalidone
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Chlortalidone 50mg tablets
0202010F0AAAAAA
|
Chlortalidone | Chlortalidone | Cardiovascular System | 3,823 |
|
Chlortalidone 12.5mg tablets
0202010F0AAALAL
|
Chlortalidone | Chlortalidone | Cardiovascular System | 809 |
|
Hylaton 50mg tablets
0202010F0BCAAAA
|
Hylaton | Chlortalidone | Cardiovascular System | 70 |
|
Hylaton 12.5mg tablets
0202010F0BCABAL
|
Hylaton | Chlortalidone | Cardiovascular System | 2 |
|
Chlortalidone 50mg/5ml oral suspension
0202010F0AAAKAK
|
Chlortalidone | Chlortalidone | Cardiovascular System | No data available |
|
Hygroton 50mg tablets
0202010F0BBAAAA
|
Hygroton | Chlortalidone | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.